The efficacy of intravitreal triamcinolone versus aser photocoagulation in the primary treament of diabetic macular oedema

Objective: To compare the efficacy and safety of intravitreal triamcinolone injection to laser photocoagulation in the primary treatment of diabetic macular oedema. Methodology: Forty patients with newly diagnosed diabetic macular oedema were randomized into 2 groups 20 in 4mg intravitreal triamc...

Full description

Bibliographic Details
Main Author: Mustafa, Norlaili
Format: Thesis
Language:English
Published: 2008
Subjects:
Online Access:http://eprints.usm.my/50831/
http://eprints.usm.my/50831/1/DR.%20NORLAILI%20BINTI%20MUSTAFA-24%20pages.pdf
_version_ 1848881826267922432
author Mustafa, Norlaili
author_facet Mustafa, Norlaili
author_sort Mustafa, Norlaili
building USM Institutional Repository
collection Online Access
description Objective: To compare the efficacy and safety of intravitreal triamcinolone injection to laser photocoagulation in the primary treatment of diabetic macular oedema. Methodology: Forty patients with newly diagnosed diabetic macular oedema were randomized into 2 groups 20 in 4mg intravitreal triamcinolone acetonide (IVT A) injection of and 20 in laser photocoagulation group. Evaluation was done at three months and the macular oedema was quantified using HRT II. Intraocular pressure elevation, lenticular opacity and endophthalmitis were observed. Results: Mean visual acuity for IVTA group was 0.935(0.223) at baseline and 0.405(0.223) at three months, p<0.01. Mean visual acuity for laser group was 0.795(0.315) at baseline and 0.525(0.289) at three months, p<0.01. However, there was no statistically significant difference between the two groups, p=0.151. Mean macular oedema index for IVTA group was 2.539 (0.914) at baseline and 1.753 (0.577) at three months, p<0.01. Mean macular oedema index for laser group was 2.139 (0.577) at baseline and 1.711(0.472) at three months, p<0.01. However, there was no statistically significant difference between the two groups (p=0.811 ). The mean intraocular pressure was statistically significant pre and post IVT A injection (p=0.032). There was no significant cataract progression at three months in both groups, p=0.688 and no incidence of endophthalmitis post IVT A injection at three months review. Conclusion: Both IVT A and laser photocoagulation demonstrate good outcome as primary treatment in diabetic macular oedema patients. The IVTA is a relatively safe procedure.
first_indexed 2025-11-15T18:25:11Z
format Thesis
id usm-50831
institution Universiti Sains Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T18:25:11Z
publishDate 2008
recordtype eprints
repository_type Digital Repository
spelling usm-508312021-12-06T08:53:44Z http://eprints.usm.my/50831/ The efficacy of intravitreal triamcinolone versus aser photocoagulation in the primary treament of diabetic macular oedema Mustafa, Norlaili R Medicine Objective: To compare the efficacy and safety of intravitreal triamcinolone injection to laser photocoagulation in the primary treatment of diabetic macular oedema. Methodology: Forty patients with newly diagnosed diabetic macular oedema were randomized into 2 groups 20 in 4mg intravitreal triamcinolone acetonide (IVT A) injection of and 20 in laser photocoagulation group. Evaluation was done at three months and the macular oedema was quantified using HRT II. Intraocular pressure elevation, lenticular opacity and endophthalmitis were observed. Results: Mean visual acuity for IVTA group was 0.935(0.223) at baseline and 0.405(0.223) at three months, p<0.01. Mean visual acuity for laser group was 0.795(0.315) at baseline and 0.525(0.289) at three months, p<0.01. However, there was no statistically significant difference between the two groups, p=0.151. Mean macular oedema index for IVTA group was 2.539 (0.914) at baseline and 1.753 (0.577) at three months, p<0.01. Mean macular oedema index for laser group was 2.139 (0.577) at baseline and 1.711(0.472) at three months, p<0.01. However, there was no statistically significant difference between the two groups (p=0.811 ). The mean intraocular pressure was statistically significant pre and post IVT A injection (p=0.032). There was no significant cataract progression at three months in both groups, p=0.688 and no incidence of endophthalmitis post IVT A injection at three months review. Conclusion: Both IVT A and laser photocoagulation demonstrate good outcome as primary treatment in diabetic macular oedema patients. The IVTA is a relatively safe procedure. 2008 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/50831/1/DR.%20NORLAILI%20BINTI%20MUSTAFA-24%20pages.pdf Mustafa, Norlaili (2008) The efficacy of intravitreal triamcinolone versus aser photocoagulation in the primary treament of diabetic macular oedema. Masters thesis, Universiti Sains Malaysia.
spellingShingle R Medicine
Mustafa, Norlaili
The efficacy of intravitreal triamcinolone versus aser photocoagulation in the primary treament of diabetic macular oedema
title The efficacy of intravitreal triamcinolone versus aser photocoagulation in the primary treament of diabetic macular oedema
title_full The efficacy of intravitreal triamcinolone versus aser photocoagulation in the primary treament of diabetic macular oedema
title_fullStr The efficacy of intravitreal triamcinolone versus aser photocoagulation in the primary treament of diabetic macular oedema
title_full_unstemmed The efficacy of intravitreal triamcinolone versus aser photocoagulation in the primary treament of diabetic macular oedema
title_short The efficacy of intravitreal triamcinolone versus aser photocoagulation in the primary treament of diabetic macular oedema
title_sort efficacy of intravitreal triamcinolone versus aser photocoagulation in the primary treament of diabetic macular oedema
topic R Medicine
url http://eprints.usm.my/50831/
http://eprints.usm.my/50831/1/DR.%20NORLAILI%20BINTI%20MUSTAFA-24%20pages.pdf